Internal Medicine · New York, NY
NPI
1043381569
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
139 Centre St, Suite 501
New York, NY, 10013
Phone (212) 274-9870
Groups this clinician bills Medicare through
Medicare paid, 2024
$69K
1,017 services
Medicare patients, 2024
93
Average age 78
Drug cost, 2024
$4.4M
39,281 prescriptions
Company payments, 2025
$879
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wei G Lin was code 99214 (office e&m - established), 251 times for 86 patients. In total Wei G Lin billed 1,017 services in 21 codes, and Medicare paid $69K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 251 | 86 | $95.41 | $24K |
| 99213 Office E&M - Established | Office | 236 | 82 | $63.54 | $15K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 193 | 81 | $49.01 | $9,458 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 56 | 56 | $144.35 | $8,084 |
| 99212 Office E&M - Established | Office | 56 | 32 | $31.00 | $1,736 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 51 | 51 | $21.23 | $1,083 |
| G0008 Administration of influenza virus vaccine | Office | 48 | 48 | $29.40 | $1,411 |
| 90662 Vaccine Product | Office | 47 | 47 | $73.47 | $3,453 |
| 99491 Chronic, Principal, and Transitional Care Management | Office | 42 | 40 | $74.62 | $3,134 |
| 96401 Chemotherapy Administration | Office | 16 | 11 | $63.56 | $1,017 |
By year: 2022 $79K for 1,085 services; 2023 $75K for 1,094 services; 2024 $69K for 1,017 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wei G Lin prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 2,152 prescriptions and refills. In total Wei G Lin wrote 39,281 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 2,152 | 2,497 | 281 | $856K |
| Rosuvastatin Calcium Generic | 1,982 | 2,609 | 255 | $10K |
| Amlodipine Besylate Generic | 1,923 | 2,560 | 259 | $7,788 |
| Atorvastatin Calcium Generic | 1,462 | 1,883 | 177 | $6,935 |
| Raloxifene Hcl Generic | 1,402 | 1,808 | 178 | $19K |
| Metoprolol Succinate Generic | 1,307 | 1,658 | 179 | $9,959 |
| Gabapentin Generic | 1,130 | 1,377 | 183 | $5,960 |
| Losartan Potassium Generic | 1,126 | 1,473 | 141 | $5,230 |
| Tamsulosin Hcl Generic | 1,091 | 1,375 | 136 | $8,417 |
| Metformin Hcl Generic | 1,009 | 1,351 | 128 | $4,436 |
| Alendronate Sodium Generic | 999 | 1,269 | 131 | $4,092 |
| Allopurinol Generic | 686 | 872 | 81 | $3,023 |
| Amitriptyline Hcl Generic | 670 | 756 | 111 | $4,235 |
| Clopidogrel Clopidogrel Bisulfate | 664 | 805 | 81 | $2,844 |
| Esomeprazole Magnesium Generic | 602 | 711 | 110 | $9,429 |
Brand drugs: 7,013 claims; generic drugs: 31,803 claims; opioid claims: 49.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wei G Lin $879 ($879 in general payments such as food, travel and fees) from 7 companies. The largest payer was Amgen Inc. with $394.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.